Barry Peters, Vice President of Corporate Quality and Compliance, Telerx
Heather D. Ferrence, Director of Corporate Compliance, Telerx
Every pharmaceutical, biotech and device company has faced Adverse Events (AE) and Product Quality Complaints (PQC) daily. Depending on a number of factors, those issued may have been minor or garnered front-page news and endangered the company’s reputation. Nonetheless, as the industry faces increased regulations and competition, many have turned to Business Process Outsourcing (BPO) firms to help them overcome the challenges and problems surrounding AEs and PQCs.